Nora MEBAREK
18 215
votes enregistrés
97%
taux de participation
92%
cohésion avec son groupe (300 derniers votes)
Répartition des votes
Pour
66%
(11937)
Contre
29%
(5337)
Abstention
2%
(396)
Absent
3%
(545)
Historique des groupes
S&D
Progressive Alliance of Socialists and Democrats
16/07/2024 →
aujourd'hui
S&D
Progressive Alliance of Socialists and Democrats
01/02/2020 →
15/07/2024
Votes 17 670 au total
10/07/2020
The revision of the guidelines for trans-European energy infrastructure
✓ Adopté
▲ Pour
10/07/2020
Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis
✓ Adopté
▲ Pour
10/07/2020
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease
✓ Adopté
▲ Pour
10/07/2020
Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis
✗ Rejeté
▼ Contre
10/07/2020
Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis
✗ Rejeté
▼ Contre
10/07/2020
Emission limits and type-approval for internal combustion engines for non-road mobile machinery: transitional provisions in order to address the impact of COVID-19 crisis
✗ Rejeté
▼ Contre
10/07/2020
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease
✗ Rejeté
▼ Contre
10/07/2020
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease
✗ Rejeté
▼ Contre
10/07/2020
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease
✗ Rejeté
▼ Contre
10/07/2020
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease
✗ Rejeté
▼ Contre
10/07/2020
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease
✗ Rejeté
▼ Contre
10/07/2020
Conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or pent coronavirus disease
✗ Rejeté
▼ Contre
09/07/2020
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor
✓ Adopté
▲ Pour
09/07/2020
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor
✓ Adopté
▲ Pour
09/07/2020
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, dimethomorph, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, formetanate, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and S-metolachlor
✓ Adopté
▲ Pour
09/07/2020
Guidelines for the employment policies of the Member States
✓ Adopté
▲ Pour
09/07/2020
Guidelines for the employment policies of the Member States
✓ Adopté
▲ Pour
09/07/2020
European Parliament recommendation to the Council and the Commission concerning the conclusion of an agreement, under negotiation, between the European Union and New Zealand on the exchange of personal data between the European Union Agency for Law Enforcement Cooperation (Europol) and the New Zealand authorities competent for fighting serious crime and terrorism
✓ Adopté
▲ Pour
09/07/2020
European citizens’ initiative: temporary measures concerning the time limits for the collection, verification and examination stages in view of the COVID-19 outbreak
✓ Adopté
▲ Pour
09/07/2020
European Parliament recommendation to the Council and the Commission concerning the conclusion of an agreement, under negotiation, between the European Union and New Zealand on the exchange of personal data between the European Union Agency for Law Enforcement Cooperation (Europol) and the New Zealand authorities competent for fighting serious crime and terrorism
✓ Adopté
▲ Pour